Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-142,484
Closed -$1.56M 260
2024
Q1
$1.56M Buy
142,484
+1,735
+1% +$10.4K 0.09% 190
2023
Q4
$517K Sell
140,749
-11,241
-7% -$28.4K 0.03% 245
2023
Q3
$468K Sell
151,990
-2,989
-2% -$13.7K 0.03% 243
2023
Q2
$739K Buy
154,979
+6,525
+4% +$36K 0.04% 232
2023
Q1
$643K Buy
148,454
+8,695
+6% +$55.4K 0.04% 241
2022
Q4
$690K Sell
139,759
-11,041
-7% -$137K 0.04% 240
2022
Q3
$2.54M Sell
150,800
-2,672
-2% -$49.1K 0.15% 159
2022
Q2
$1.47M Buy
153,472
+46,432
+43% +$778K 0.07% 217
2022
Q1
$2.8M Buy
+107,040
New +$3.01M 0.11% 177

Other funds holding NOTV

Rice Hall James & Associates's NOTV Position: Q2 2024 in Review

Rice Hall James & Associates sold out of Inotiv (NOTV) in Q2 2024, closing a stake of 142,484 shares — an estimated $1.56M sold.

Rice Hall James & Associates first reported a position in NOTV in Q1 2022 and held it in 9 quarters. The position peaked at $2.8M in Q1 2022. 57 funds tracked by Wall St. Rank hold NOTV as of Q2 2024.

  • Rice Hall James & Associates reported no remaining Inotiv position as of Q2 2024 after selling out during the quarter.
  • Rice Hall James & Associates sold 142,484 Inotiv shares in Q2 2024, an estimated $1.56M.
  • Rice Hall James & Associates first reported a position in Inotiv in Q1 2022 and held it in 9 quarters.
  • Rice Hall James & Associates's Inotiv position peaked at $2.8M in Q1 2022.
  • 57 funds tracked by Wall St. Rank held Inotiv as of Q2 2024.

Based on Rice Hall James & Associates's 13F filing for Q2 2024, filed 7 Aug 2024.